Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic and Wegovy in 2023, a 500 percent increase from their spending on such drugs five years earlier, according to a research ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved for this use. Both drugs are approved for ...

Novo Nordisk works with Hims & Hers, Ro, LifeMD to expand Wegovy access Hims & Hers, LifeMD shares jump more than 25% and 36% respectively Danish drugmaker says move is "very clear message" Wegovy ...